Login
From:
Forbes
(Uncensored)
subscribe
How A 60-Year-Old Drug Developer Built $4.4 Billion Krystal Biotech To Treat ‘Butterfly Skin Disease’
https://www.forbes.com/sites/amyfeldman/2025/07/31/the-butterfly-skin-disease-centimillionaire/
links
backlinks
Tagged with:
business
healthcare
innovation
Longtime drug developer Suma Krishnan was 51 when she cofounded Krystal Biotech. Now the company has one gene therapy on the market and more in the works.
Roast topics
Find topics
Find it!
